These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25440002)

  • 21. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
    Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
    Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
    [No Abstract]   [Full Text] [Related]  

  • 22. Anaphylactoid reaction to recombinant tissue plasminogen activator.
    Krmpotic KR; Fernandes CM
    Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal Intraperitoneal Bleeding after Intravenous Administration of Tissue Plasminogen Activator.
    Anan C; Oomura M; Saeki T; Ikeda T; Sato C; Yamada K
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e177-8. PubMed ID: 25899160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
    Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
    Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients.
    Ottomeyer C; Hennerici MG; Szabo K
    Cerebrovasc Dis; 2009; 27(3):307-8. PubMed ID: 19208988
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 27. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.
    Georgiadis D; Engelter S; Tettenborn B; Hungerbühler H; Luethy R; Müller F; Arnold M; Giambarba C; Baumann CR; von Büdingen HC; Lyrer P; Baumgartner RW
    Circulation; 2006 Jul; 114(3):237-41. PubMed ID: 16831985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenic hemorrhage after tissue plasminogen activator for acute myocardial infarction.
    Blankenship J; Indeck M
    N Engl J Med; 1991 Sep; 325(13):969. PubMed ID: 1908949
    [No Abstract]   [Full Text] [Related]  

  • 30. Hazards of thrombolytic therapy for stroke: the real-world experience.
    Hurley JC
    Intern Med J; 2007 May; 37(5):348-9; author reply 349-50. PubMed ID: 17504292
    [No Abstract]   [Full Text] [Related]  

  • 31. Do risks outweigh benefits in thrombolysis for stroke?
    Brown SG; Macdonald SP; Hankey GJ
    BMJ; 2013 Aug; 347():f5215. PubMed ID: 23990634
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
    Cheong E; Dodd L; Smith W; Kleinig T
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage.
    Cucchiara B; Kasner S; Tanne D; Levine S; Demchuk A; Messe S; Sansing L; Lees K; Lyden P;
    Int J Stroke; 2011 Apr; 6(2):109-11. PubMed ID: 21371270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 38. The risk of thrombolysis in "stroke mimics": a case report.
    Knaïssi N; Derex L; Cho TH; Marnet D; Nighoghossian N
    Neurol Sci; 2011 Oct; 32(5):973-5. PubMed ID: 21153597
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.